OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16

Showing 16 citing articles:

HER2+ advanced gastric cancer: Current state and opportunities (Review)
Hui-Hui Hu, Saiqi Wang, Huichen Zhao, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 9

Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T
Jiajia Wang, Huiping Wang, Yangyang Ding, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Development of a CD39 nanobody and its enhancement to chimeric antigen receptor T cells efficacy against ovarian cancer in preclinical studies
Yuchen Zhang, Xian-Yang Li, Qi Deng, et al.
Theranostics (2024) Vol. 14, Iss. 16, pp. 6249-6267
Open Access | Times Cited: 4

Blood cancer therapy with synthetic receptors and CRISPR technology
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access

Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access

Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access

Secretory exosomes from modified immune cells against cancer
Asrin Mafakheri, Fardin Fathi, Jamal Majidpoor, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy
Nele Prasse, Charlotte Wessolowski, Ingo Müller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5344-5344
Open Access | Times Cited: 1

Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells
Dan Cappabianca, Jingling Li, Yueting Zheng, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access

CAR-T cell therapy: breakthroughs, challenges and emerging horizons in cancer treatment
Rajeev Goel
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 12, pp. 4829-4841
Open Access

Physiological markers for immunotherapeutics: a review
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access

Page 1

Scroll to top